Cargando…
Molecular Signatures in Ductal Carcinoma In Situ (DCIS): A Systematic Review and Meta-Analysis
Context: Adjuvant radiotherapy (RT) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) is debated as benefits are inconstant. Molecular signatures for DCIS have been developed to stratify the risk of local recurrence (LR) and therefore guide the decision of RT. Objective: To e...
Autores principales: | Ouattara, Drissa, Mathelin, Carole, Özmen, Tolga, Lodi, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004217/ https://www.ncbi.nlm.nih.gov/pubmed/36902822 http://dx.doi.org/10.3390/jcm12052036 |
Ejemplares similares
-
Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002) -
Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast
por: Badve, Sunil S., et al.
Publicado: (2021) -
Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004) -
Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004) -
Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)